Physician profile
Rabie Shanti
NPI 1811202633
$25,401.27
in general payments reported to CMS, 2019-2025
13 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what 88% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $8,580 · 2022: $10K · 2023: $670 · 2024: $3,693 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,290 · Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,290.00 |
| Food and Beverage | $1,770.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $22,008.34 | 2019-2025 | Na, Trumatch, Matrixcombo |
| Depuy Synthes Sales INC. | $2,561.65 | 2019-2025 | Trumatch, Na, Matrixmandible |
| Kerecis Limited | $191.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimvie INC. | $136.84 | 2024 | |
| Axogen | $131.25 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Royal Biologics, INC. | $95.31 | 2025 | |
| Nobel Biocare USA | $78.44 | 2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $59.22 | 2023-2024 | Traumaone, Tmj System |
| Straumann USA LLC | $49.68 | 2024-2025 | |
| Stryker Corporation | $36.45 | 2025 | Core |
| Medtronic, INC. | $19.08 | 2025 | Nim-Response |
| Checkpoint Surgical, INC | $18.75 | 2024 | Checkpoint Stimulators |
| Cook Medical LLC | $14.64 | 2023 | Biodesign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabie Shanti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.